maximum-level resistance to HIV-1 superinfection.
Results
that the decrease in CCR5 levels was not simply a consequence of a co-downmodulation with CD4 mediated by the preassociation of both molecules at the plasma Expression of HIV-1 Nef Protects Cells from Superinfection, but Downmodulation of the CD4 membrane [19] . Importantly, marked downmodulation of CCR5 was also detected in activated primary human Entry Receptor only Partly Accounts for this Inhibitory Activity peripheral blood lymphocytes (PBLs) Nef.GFP reduced cell-surface mechanism in addition to CD4 downmodulation during levels of CCR5 and CD4 by 53% and 76%, respectively the early phase of the virus-host-cell interaction.
( Figure 1F ). Overnight treatment of cells with 100 nM of RANTES resulted in a 51% reduction of surface-CCR5 levels but did not significantly affect surface presenta-
HIV-1 Nef Expression Downmodulates Cell-Surface tion of CD4. This degree of RANTES-mediated CCR5 Levels of the Chemokine Coreceptor CCR5
downmodulation was comparable to what has been reBecause HIV-1 entry critically depends on the primary ported by others [21] , and higher concentrations of entry receptor CD4 and a human chemokine corecep-RANTES did not further enhance CCR5 downmodulator, we investigated whether Nef also affects cell-surtion (data not shown). Thus, expression of Nef reduces face levels of the major HIV-1 coreceptor CCR5, which cell-surface levels of CCR5 as efficiently as a natural is utilized by most HIV strains [18] . We examined the β-chemokine ligand does. We next compared CCR5 downmodulation by Nef prothe levels in GFP-expressing control cells (left panels), teins from multiple HIV-1 strains, from HIV-2, and from CD4 and CCR5 levels were downregulated in a concen-SIV (Figure 2A) . The reduction of cell-surface CD4 levels tration-dependent manner on cells transiently expressserved as an internal reference and ranged between ing Nef.GFP (right panels). To quantify the reductions 71% and 79% for the various Nef proteins analyzed. induced by Nef, we compared, within the same sample, Remarkably, all Nef proteins significantly reduced receptor levels on non-GFP-expressing cells (gate R2) steady-state cell-surface levels of CCR5 with efficienwith receptor levels on cells with medium GFP-exprescies of 35%-73%. No significant difference in CCR5 sion levels (gate R3). Accordingly, Nef.GFP expression downregulation was detected between Nef proteins dereduced the levels of CCR5 and CD4 on the cell surface rived from HIV-1 isolates that use either only CXCR4 by 70% and 81%, respectively. Thus, HIV-1 Nef induces (e.g., NL4-3) or both CCR5 and CXCR4 (e.g., SF2) were a reduction in cell-surface exposure of the entry recepused as entry coreceptors. Thus, the ability of Nef to tor CD4 and, as a novel finding, also of the major coredownmodulate CCR5 is conserved in lentiviral evoluceptor CCR5.
tion and is independent of the coreceptor specificity of the corresponding Env protein.
Nef Downmodulates CCR5 in HIV-1 Infected Cells via a Ubiquitous Cellular Machinery
Nef Employs Distinct Signature Motifs to Regulate CD4 and CCR5 Transient expression of Nef induced a marked reduction in the surface levels of both receptors in several To identify the molecular determinants required for CCR5 regulation in Nef, we analyzed several well-charadherent and T cell lines of human and rodent origin. The remaining surface levels were 33%-65% and 11%-acterized HIV-1 Nef mutants [11] . All mutants were expressed to comparable levels either as GFP fusion pro-38% for CCR5 and CD4, respectively, of the levels of GFP-expressing control cells ( Figure 1D was assessed in parallel. In cells expressing Nef.GFP diated enhancement of CD4 endocytosis, whereas or the NefEDAA mutant, the surface exposure of MHC-I treatment with the CCR5 ligand RANTES had no effect was also markedly reduced, and importantly, MHC-I on this receptor ( Figure 3B) . and CCR5 colocalized to a significant degree in the Regarding the signature motifs required for this activperinuclear clusters. Of note, colocalization was not as ity, Nef and the NefEDAA mutant accelerated internalpronounced for vesicular structures found toward the ization of CCR5 with comparable efficiencies, but Nefcell periphery. Interestingly, in the presence of Nef, CD4 AxxA had only a slight effect ( Figure 3C ). In contrast, also accumulated in the perinuclear region and partially Nef and NefAxxA, but not NefEDAA, markedly encolocalized with CCR5 ( Figure S4 ). In summary, medihanced the endocytosis rate of CD4 ( Figure 3D ). Thus, ated by identical motifs, Nef targets CCR5 and MHC-I the Nef determinants required for CCR5 downregulato the same perinuclear compartment where all three tion at steady state also mediate the acceleration of receptor endocytosis. Furthermore, these results sugmolecules colocalize to a significant extent. 
Discussion
This study establishes that the accessory protein Nef of primate lentiviruses efficiently protects cells from superinfection. Although the Nef-mediated downregulation of the primary entry receptor CD4 significantly contributes to this activity, it is insufficient for the maximum level of protection. The chemokine receptor CCR5, which serves as the major coreceptor for most HIV isolates and whose cell-surface level is critical for virus entry, was identified as a novel and functionally important target of Nef. Nef downregulated cell-surfaceexposed CCR5 as efficiently as the natural β-chemokine ligand RANTES did. Notably, the downregulation of CCR5 in the context of HIV-1 infection was reported in a previous study, although the responsible viral gene product was not determined [27] . In the current study, expression of the early gene product Nef establishes superinfection immunity via mechanistically distinct yet functionally synergistic strategies that target both components of the HIV receptor complex. Nef downmodulates CCR5 and CD4 from the cell surface by enhancing receptor internalization and degradation via genetically separable activities. Whereas the downmodulation of CCR5 involves the SH3-and PACS-interacting motifs, effects of Nef on CD4 cell-surface levels depend on motifs linked 
